Lite Strategy, Inc. (LITS): Operating Income
-$66.58M
Year ended 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | -$66.58M | n/m | 2026-09-28, From 2025-07-01 |
| 2025-06-30 | -$17.45M | n/m | 2026-09-28, From 2024-07-01 |
| 2024-06-30 | $14.54M | n/m | 2025-09-26, From 2023-07-01 |
| 2023-06-30 | -$36.76M | n/m | 2024-09-19, From 2022-07-01 |
| 2022-06-30 | -$75.48M | n/m | 2023-09-26, From 2021-07-01 |
| 2021-06-30 | -$60.42M | n/m | 2022-09-08, From 2020-07-01 |
| 2020-06-30 | -$25.70M | n/m | 2022-09-08, From 2019-07-01 |
| 2019-06-30 | -$46.24M | n/m | 2022-05-23, From 2018-07-01 |
| 2018-06-30 | -$28.59M | n/m | 2020-09-09, From 2017-07-01 |
| 2017-06-30 | $2.38M | n/m | 2019-08-28, From 2016-07-01 |
| 2016-06-30 | -$21.00M | n/m | 2018-08-30, From 2015-07-01 |
| 2015-06-30 | -$32.77M | n/m | 2017-09-05, From 2014-07-01 |
| 2014-06-30 | -$27.23M | n/m | 2016-09-06, From 2013-07-01 |
| 2013-06-30 | -$11.22M | n/m | 2015-09-02, From 2012-07-01 |
| 2012-06-30 | -$8.39M | n/m | 2014-09-09, From 2011-07-01 |
| 2011-06-30 | -$6.45M | n/a | 2012-09-18, From 2010-07-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | 2026-06-30 | -$66.58M | n/m |
| Cue Biopharma, Inc. (CUE) | 2025-12-31 | -$26.55M | n/m |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | -$50.46M | n/m |
| Medicinova Inc (MNOV) | 2025-12-31 | -$13.28M | n/m |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | -$40.11M | n/m |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | -$12.19M | n/m |
| Jaguar Health, Inc. (JAGX) | 2025-12-31 | -$45.91M | n/m |
| Atossa Therapeutics, Inc. (ATOS) | 2025-12-31 | -$37.14M | n/m |
| Theriva Biologics, Inc. (TOVX) | 2025-12-31 | -$24.05M | n/m |
Compare LITS, CUE, BTAIQ, MNOV side by side · Screen every company in Pharmaceutical Preparations ↗